The Canadian Foundation for Global Health Announces a Research and Development Partnership with Medizone International, Inc.

    OTTAWA, Feb. 18 /CNW/ -- It was announced today that Medizone
International's (Pink Sheets:   MZEI) AsepticSure(TM) hospital sterilization
system is being developed under the direction of Dr. Michael E. Shannon of the
Canadian Foundation for Global Health. Dr. Shannon was recently appointed
President of the Canadian Foundation for Global Health.  He also serves as a
board member of Medizone International and is the Company's Director of
Medical Affairs.
    The Medizone AsepticSure(TM) system is described as a portable
decontamination and sterilization system for hospitals, government buildings,
schools and other functionally critical environments that might currently
require, or need to be prepared for, countermeasures capability from
contamination by infectious biological agents such as C difficile, E coli,
Pseudomonas aeruginous, MRSA and VRE.  The AsepticSure(TM) system is designed
to sterilize the space and then return it to full service in two hours or
    Dr. Shannon stated that "this research partnership is the first for the
Foundation and he expects that it will establish a model for other projects in
the future. Presently, the Foundation is fully occupied in developing this
sterilization program. We are currently identifying principal investigators as
well as a suitable research institution at which we plan to focus most of our
microbiology for this exciting project. Our intention is to begin independent
university trials in the spring with the goal of validating the effectiveness
of our new system across a broad range of bacterial and viral pathogens. This
will be quickly followed by actual hospital beta testing to confirm the
practicability of our decontamination protocols. Based upon innovative new
engineering approaches, we remain confident that this research will reliably
demonstrate 5 log reductions for most, if not all, of these often fatal
bacteria. The implications of such work are indeed profound as these pathogens
are considered to be the main causative agents of hospital derived infections
and collectively account for tens of thousands of lives lost each year in the
US alone.  So far we have received a high level of interest from hospitals in
both the United States and Canada and expect that if the university trials are
as successful as we anticipate, it will be a smooth transition to hospital
beta testing of the prototype design which is expected to begin during the 3rd
quarter of 2009."
    The Canadian Foundation for Global Health is a federally chartered not
for profit Canadian Corporation.  It has been established to assist in the
research and development of novel and advanced emerging technologies in the
field of science and medicine deemed to be of benefit to humanity.
    Medizone International, Inc., is a research and development stage company
engaged in the development of patented and unpatented technologies and
protocols for O3 based bio-oxidative treatment of diseases caused by lipid
enveloped viruses, including Acquired Immune Deficiency Syndrome (AIDS),
Hepatitis B & C, and Herpes, the decontamination of blood, blood products and
veterinarian serum products, and the treatment of external pathogenic
conditions. It is currently developing technology to decontaminate and
sterilize hospital surgical suites, emergency rooms and intensive care units.
    This Press Release contains certain forward looking statements that
involve substantial risks and uncertainties, including, but not limited to,
the results of ongoing clinical studies, economic conditions, product and
technology development, production efficiencies, product demand, competitive
products, competitive environment, successful testing and government
regulatory issues. Additional risks are identified in the company's filings
made with the Securities and Exchange Commission.
    Contact for the Canadian Foundation for Global Health  613-231-8555
    Investor Relations, Medizone International: 800-953-3350 /
    web site:


For further information:

For further information: Canadian Foundation for Global Health,
+1-613-231-8555; Investor Relations, Medizone International, 1-800-953-3350
Web Site:

Organization Profile

Medizone International, Inc.

More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890